KRENSAVAGE ASSET MANAGEMENT, LLC Holdings
KRENSAVAGE ASSET MANAGEMENT, LLC is an investment fund managing more than 314.06M US dollars. The largest holdings include Biogen, United Therapeutics and Regeneron Pharmaceuticals. In Q3 2022 the fund bought assets of total value of 32.81M US dollars and sold assets of total value of 21.24M US dollars.
KRENSAVAGE ASSET MANAGEMENT, LLC portfolio value:
KRENSAVAGE ASSET MANAGEMENT, LLC quarter portfolio value change:
KRENSAVAGE ASSET MANAGEMENT, LLC 1 year portfolio value change:
KRENSAVAGE ASSET MANAGEMENT, LLC 3 years portfolio value change:
KRENSAVAGE ASSET MANAGEMENT, LLC 5 years portfolio value change:
KRENSAVAGE ASSET MANAGEMENT, LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2016 | -23503000 | 6603000 |
| Q2 2016 | 35463000 | 10630000 |
| Q3 2016 | 18929000 | 18065000 |
| Q4 2016 | 63696000 | 57782000 |
| Q1 2017 | 69951000 | 14983000 |
| Q2 2017 | 16696000 | 10381000 |
| Q3 2017 | 11985000 | 7026000 |
| Q4 2017 | 39413000 | 38805000 |
| Q1 2018 | 127068000 | 10183000 |
| Q2 2018 | 8138000 | 29175000 |
| Q3 2018 | 40149000 | 29815000 |
| Q4 2018 | -31479000 | 40170000 |
| Q1 2019 | 84929000 | 5843000 |
| Q2 2019 | -18455000 | 35998000 |
| Q3 2019 | 5284000 | 47387000 |
| Q4 2019 | 103645000 | 69898000 |
| Q1 2020 | 22489000 | 1583000 |
| Q2 2020 | 40001000 | 4955000 |
| Q3 2020 | -1334000 | 33537000 |
| Q4 2020 | 15261000 | 13069000 |
| Q1 2021 | 11979000 | 65506000 |
| Q2 2021 | 14829000 | 9184000 |
| Q3 2021 | 15148000 | 9090000 |
| Q4 2021 | -3605000 | 26863000 |
| Q1 2022 | 709000 | 1112000 |
| Q2 2022 | 22240000 | 9880000 |
| Q3 2022 | 32805000 | 21236000 |
KRENSAVAGE ASSET MANAGEMENT, LLC 13F holdings
| Stock |
|---|
| Portfolio share: 15.70% Portfolio value: 49.30M Avg. open price: $249.15 Current price: $292.75 P/L: +17.50% Bought +57.48% shares Q3 2022 |
| Portfolio share: 13.36% Portfolio value: 41.96M Avg. open price: $132.57 Current price: $273.72 P/L: +106.47% Sold -0.41% shares Q3 2022 |
| Portfolio share: 13.36% Portfolio value: 41.94M Avg. open price: $599.45 Current price: $755.45 P/L: +26.02% Bought +0.84% shares Q3 2022 |
| Portfolio share: 10.04% Portfolio value: 31.52M Avg. open price: $17.22 Current price: $25.51 P/L: +48.14% Bought +0.97% shares Q3 2022 |
| Portfolio share: 9.73% Portfolio value: 30.57M Avg. open price: $50.41 Current price: $43.06 P/L: -14.58% Sold -5.67% shares Q3 2022 |
| Portfolio share: 9.39% Portfolio value: 29.48M Avg. open price: $25.32 Current price: $33.83 P/L: +33.61% Bought +0.69% shares Q3 2022 |
| Portfolio share: 9.09% Portfolio value: 28.56M Avg. open price: $21.02 Current price: $17.22 P/L: -18.10% Bought +20.88% shares Q3 2022 |
| Portfolio share: 7.15% Portfolio value: 22.45M Avg. open price: $54.54 Current price: $79.48 P/L: +45.73% Bought +88.29% shares Q3 2022 |
| Portfolio share: 5.54% Portfolio value: 17.41M Avg. open price: $74.29 Current price: $30.33 P/L: -59.17% Bought +0.05% shares Q3 2022 |
| Portfolio share: 3.45% Portfolio value: 10.84M Avg. open price: $141.13 Current price: $382.44 P/L: +170.99% Sold -61.50% shares Q3 2022 |
| Portfolio share: 1.16% Portfolio value: 3.63M Avg. open price: $7.72 Current price: $7.26 P/L: -5.96% Sold -15.30% shares Q3 2022 |
| Portfolio share: 1.02% Portfolio value: 3.19M Avg. open price: $44.95 Current price: $33.96 P/L: -24.44% Bought +0.06% shares Q3 2022 |
| Portfolio share: 0.98% Portfolio value: 3.08M Avg. open price: N/A Current price: $10.61 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.03% Portfolio value: 86K Avg. open price: $7.43 Current price: $1.4 P/L: -81.17% Bought +0.96% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.32 P/L: N/A Sold -100.00% shares Q3 2022 |
Showing TOP 15 KRENSAVAGE ASSET MANAGEMENT's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of KRENSAVAGE ASSET MANAGEMENT, LLC?
The biggest position of the KRENSAVAGE ASSET MANAGEMENT, LLC is Biogen Inc. (BIIB) with 15.7% portfolio share worth of 49.3M US dollars.
Top 5 KRENSAVAGE ASSET MANAGEMENT's holdings represent 62.18% of the portfolio:
- Biogen Inc. (BIIB) – 15.7%
- United Therapeutics Corporation (UTHR) – 13.36%
- Regeneron Pharmaceuticals, Inc. (REGN) – 13.36%
- Alkermes plc (ALKS) – 10.04%
- Enanta Pharmaceuticals, Inc. (ENTA) – 9.73%
Who is the portfolio manager of KRENSAVAGE ASSET MANAGEMENT, LLC?
The portfolio manager of the KRENSAVAGE ASSET MANAGEMENT, LLC is .
What is the total asset value of the KRENSAVAGE ASSET MANAGEMENT, LLC portfolio?
KRENSAVAGE ASSET MANAGEMENT, LLC total asset value (portfolio value) is 314.06M US dollars.
Who is ?
is the portfolio manager of the KRENSAVAGE ASSET MANAGEMENT, LLC.
What is (KRENSAVAGE ASSET MANAGEMENT, LLC) fund performance?
KRENSAVAGE ASSET MANAGEMENT's quarterly performance is -1.93%, annualy -1.06%. In the past 3 years, the value of 's portfolio has increased by +52%. In the past 5 years, the value of the portfolio has increased by +54%.
What is the KRENSAVAGE ASSET MANAGEMENT, LLC CIK?
KRENSAVAGE ASSET MANAGEMENT's Central Index Key is 0001609251 .